Efficacy and Safety of SSRI in Overactive Bladder Patients; a 3-Month, Prospective, Open-Label, Comparative Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Escitalopram; Muscarinic receptor antagonists
- Indications Overactive bladder
- Focus Therapeutic Use
- 26 Aug 2010 Biomarkers information updated
- 25 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record